Home Biotech Stocks Page 122

Biotech Stocks

Latest

Insys Therapeutics Presents Study Results Showing Rapid Absorption Of Epinephrine

ME Staff - February 26, 2019

Veritas Pharma Doses First Subject In Clinical Study Of CTL-X

OWC Pharmaceutical Cannabis Ointment Set To Proceed To PII After Positive PI Data

Reliq Health Technologies Expands Leadership Team As Investigations Continue

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

GlaxoSmithKline plc (NYSE:GSK) Resolves Bexsero Shortage

Andy Parker - May 18, 2016 0

What Should Aduro BioTech Inc (NASDAQ:ADRO) Investors Do Now?

Roger Hannington - May 17, 2016 0

AstraZeneca plc (ADR) (NYSE:AZN) Posts Positive Phase III Trial Results For...

Carol Harper - May 17, 2016 2

Novartis AG (NYSE:NVS) And Mylan NV (NASDAQ:MYL) Eye Teva Pharmaceutical Industries...

- May 17, 2016 0

Oramed Pharmaceuticals, Inc.(NASDAQ:ORMP) To Release Phase IIB Clinical Data On Lead...

David Rich - May 17, 2016 0

Weekly Biotech Report II – Marinus Pharmaceuticals Inc. (NASDAQ:MRNS) To Release...

David Rich - May 17, 2016 0

Novartis AG (NYSE:NVS) Ultibro Is Performing Better Than GlaxoSmithKline plc (NYSE:GSK)’s...

- May 17, 2016 0

Weekly Biotech Report Part I – FDA To Decide On AstraZeneca...

David Rich - May 16, 2016 0

All You Need To Know About Global Blood Therapeutics Inc’s (NASDAQ:GBT)...

Jennifer Aldershot - May 16, 2016 0

Mylan NV (NASDAQ:MYL) Is Buying Renaissance’s Topical Business For Around $1...

Andy Parker - May 16, 2016 0

1...121122123...146 Page 122 of 146

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24

October 13, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.